Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Interested to see what the 10K will bring
GM All, Looking at GNBP for possible bounce play. I saw a couple days ago it hit $1.35 and now it and its MACD, RSI, and ACCUM/DIST have consolidated where a bullish pop shows some potential
GNBP is starting to gather some more eyes with their past few news releses
Average Volume on DRSV: 29,741 (3Month)
Genesis Biopharma GNBP had some interesting points in the 10 K:
During 2012 and early 2013, they intend to work with their manufacturing partner, Lonza Walkersville to develop an FDA compliant manufacturing process for Contego, with the goal being to submit our investigational new drug application (IND) to the U.S. Food and Drug Administration (FDA) in late 2013.
GNBP will then seek allowance to proceed with a pivotal clinical trials for Contego for the treatment of Stage IV metastatic melanoma patients who are refractory to all FDA approved therapies for treatment of the disease.
Very cool stuff potentially coming down the pipe IMO
GNBP recently did the annual filing of their 10K. The chart looks to be setting up for what could be a bounce IMO. Charts is tapping the Moving average between the bollis' and the MACD is touching the EMA. I'll continue the DD and look for more info but I think this could be a longer term kind of play. http://ih.advfn.com/p.php?pid=nmona&article=51843734
GNBP released a 10K on Friday and I have found it to show that the company potentially has a lot in store for the upcoming 2012-2013 year! The company has aligned itself with the National Cancer Institute (NCI) where GNBP has entered into a Patent License Agreement with the National Institutes of Health, giving GNBP the non-exclusive worldwide right and license to develop and manufacture certain proprietary autologous tumor infiltrating lymphocyte adoptive cell therapy products for the treatment of metastatic melanoma, ovarian cancer, breast cancer, and colorectal
Currently no other companies commercially provide a ready-to-infuse adoptive cell therapy product that competes with Contego within the proposed market of which GNBP operates. The company estimates approximately 6,000 –7,000 Stage IV metastatic melanoma patients could be candidates for Contego annually in the U.S.; nearly 10% of the annual number of new cases within the US!
The 10K also lays out an amazing team of scientists and clinicians from all over the US who have experience with the development and use of adoptive cell therapy using autologous tumor infiltrating lymphocytes for the treatment of cancer. They will assist with GNBP's development and commercialization of Contego. Represented institutes include the Fred Hutchinson Cancer Research Center, Yale University School of Medicine, the Lee Moffitt Cancer Center & Research Institute, the Anderson Cancer Center, City of Hope, as well as University of Pennsylvania School of Medicine!
With solid goals and a strong development team shown in the release of this 10K, I see a lot of potential with GNBP, where the stock could pop like I saw several days ago, seeing highs around $1.40.
GNBP released a 10K on Friday and I have found it to show that the company potentially has a lot in store for the upcoming 2012-2013 year! The company has aligned itself with the National Cancer Institute (NCI) where GNBP has entered into a Patent License Agreement with the National Institutes of Health, giving GNBP the non-exclusive worldwide right and license to develop and manufacture certain proprietary autologous tumor infiltrating lymphocyte adoptive cell therapy products for the treatment of metastatic melanoma, ovarian cancer, breast cancer, and colorectal cancer.
A recent letter to shareholders, XSunX announced that they are now working to attach or install the balance of the major components necessary to prepare the system for testing! Build up Momentum Could show a nice chart pop this week
DRSVlooks like it's starting to get back some volume over the last couple days
DRSV partnership with Resolution Services Group to launch a new tax season web collection solution called "TaxSeasonSettlements.com(TM)" seems very applicable right now.
Just started looking at DRSV on a volume alert from my stock strategy scanner. Anyone on this board been following this?
Early volume on GLTV the momo is starting in my opinion this could be a multi day winner
GLTV thin ready to move and hearing alot of online chatter on this company
Spread is nice and tight and there is good bid support somebody wants this to move
WGAS super liquid ready to roll for today wow
$GNBP strongest open in a while. Definitely something to notice here on news as well: http://ih.advfn.com/p.php?pid=nmona&article=51730792
Looks like GNBP board appointment has some people interested in this one.
I guess what impressed me the most on GNBP was, coming from a trader's perspective, this stock came up from low dollarville and now is around a buck ten. Not to mention Hans Bishop is now the Chairman. I see you have followed this one closely and though I understand sarcasm, I'm as my name suggests, a positive person when it comes to this . GNBP is going to be on my watchlist for awhile I think :)
Got a few emails tonight on GNBP. Company actually looks pretty solid. Kinda pricey but has been moving lately
GNBP looks interesting. Got some emails about this one and thought I would join in on your board. Seems like it's starting to build up momentum from last week. Thoughts?